LYEL
Lyell Immunopharma, Inc. Common Stock
$14.74
-5.09%
-0.79
Notify me if price changes either direction
Buy LYEL stocks now with Interactive Brokers – the most advanced investment platform
Contents
- Performance
- Key stats
- Financials
- US politician trades
Loading
Key Stats
Market cap.
361.2M
Enterprise value
223.1M
Trailing PE
-1.137491871463
Forward PE
-2.4572785
PEG Ratio
0.033890221737401
Enterprise to EBITDA
-1.233
Enterprise to revenue
8261.513
Price to book MRQ
1.5540879
Price to sales TTM
14094.994
Financials
Fiscal Year Ends
2025-12-31
Most Recent Quarter (MRQ)
2026-06-30
Revenue (TTM)
27000
EBITDA
-180944000
Diluted EPS TTM
-12.69
Total Cash (MRQ)
204.1M
Current ratio (MRQ)
5.356
Operating Cash Flow (TTM)
-133260000
LYEL trades by the US politicians
Percentage
0%
0 sells
100%
0 buys
Amount
$0
0 sells
$0
0 buys
In the last 0 months
August 2026
| Senator | Action | Amount | Date | Owner | Type |
|---|---|---|---|---|---|
| Senator | Type | 100 - 200 | Jan 2024 | Finbold | Senate |
| Senator | Type | 100 - 200 | Jan 2024 | Finbold | Senate |
| Senator | Type | 100 - 200 | Jan 2024 | Finbold | Senate |
| Senator | Type | 100 - 200 | Jan 2024 | Finbold | Senate |
| Senator | Type | 100 - 200 | Jan 2024 | Finbold | Senate |
| Senator | Type | 100 - 200 | Jan 2024 | Finbold | Senate |
There are no signals yet
Keep up to date with our realtime buy and sell alerts, exclusive insights, and in-depth analysis.
